Literature DB >> 16200544

Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.

Rina J Chokshi1, Harpreet K Sandhu, Raman M Iyer, Navnit H Shah, A Waseem Malick, Hossein Zia.   

Abstract

The objective of the study was to characterize the physical and viscoelastic properties of binary mixtures of drug and selected polymers to assess their suitability for use in the hot-melt extrusion (HME) process as a means to improve solubility by manufacturing either solid dispersion or solid solution. Indomethacin (INM) was selected as a model drug. Based on comparable solubility parameters, the selected polymers were Eudragit EPO (EPO), polyvinylpyrrolidone/vinyl acetate copolymer (PVP-VA), polyvinylpyrrolidone K30 (PVPK30), and poloxamer 188 (P188). The various drug and polymer systems were characterized for thermal and rheological properties as a function of drug concentration to provide an insight into miscibility and processibility of these systems. From the thermal analysis studies, a single T(g) was observed for the binary mixtures of INM/EPO, INM/PVP-VA, and INM/PVPK30, indicating miscibility of drug and polymer in the given ratios. In the case of mixtures of INM/P188, two melting endotherms were observed with decreasing drug melting point as a function of polymer concentration indicating partial miscibility of drug in polymer. As part of the rheological evaluation, zero rate viscosity (eta(o)) and activation energy (E(a)) was determined for the various systems using torque rheometer at varying shear rates and temperatures. The eta(o) for binary mixtures of drug and EPO, PVP-VA and PVPK30 were found to be significantly lower as compared to pure polymer, indicating disruption of the polymer structure due to miscibility of the drug. On the other hand, INM/P188 mixtures showed a higher eta(o) compared to pure polymer indicating partial miscibility of drug and polymer. With respect to E(a), the mixtures of INM/EPO showed an increase in E(a) with increasing drug concentration, suggesting antiplasticization effect of the drug. These findings corroborate the thermal analysis results showing increase T(g) for the various binary mixtures. The mixtures of INM/PVP-VA showed a decrease in the E(a) with the increasing drug concentration suggesting a plasticization effect of the drug. The understanding of thermal and rheological properties of the various drug/polymer mixtures help established the processing conditions for hotmelt extrusion (such as extrusion temperatures and motor load) as well as provided insight into the properties of the final extrudates. Using the actual hot-melt processing, a model was developed correlating the zero rate viscosity to the motor load determined by rheological evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16200544     DOI: 10.1002/jps.20385

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  21 in total

1.  Processability of AquaSolve™ LG polymer by hot-melt extrusion: Effects of pressurized CO2 on physicomechanical properties and API stability.

Authors:  Mashan Almutairi; Bjad Almutairy; Sandeep Sarabu; Ahmed Almotairy; Eman Ashour; Suresh Bandari; Amol Batra; Divya Tewari; T Durig; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-04-18       Impact factor: 3.981

2.  A systematic approach to design and prepare solid dispersions of poorly water-soluble drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-02-22       Impact factor: 3.246

3.  Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulose.

Authors:  Eman A Ashour; Vijay Kulkarni; Bjad Almutairy; Jun-Bom Park; Sejal P Shah; Soumyajit Majumdar; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Scott T Martin; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2015-05-22       Impact factor: 3.225

4.  Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO.

Authors:  Taro Kojima; Kenjirou Higashi; Toyofumi Suzuki; Kazuo Tomono; Kunikazu Moribe; Keiji Yamamoto
Journal:  Pharm Res       Date:  2012-01-05       Impact factor: 4.200

5.  Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH.

Authors:  Manish Munjal; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2006-09-01       Impact factor: 3.246

6.  An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.

Authors:  Shweta R Ugaonkar; Justin T Clark; Lexie B English; Todd J Johnson; Karen W Buckheit; Robert J Bahde; Daniel H Appella; Robert W Buckheit; Patrick F Kiser
Journal:  J Pharm Sci       Date:  2015-07-06       Impact factor: 3.534

7.  Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.

Authors:  Justin S LaFountaine; Leena Kumari Prasad; Chris Brough; Dave A Miller; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-10-13       Impact factor: 3.246

8.  Rheological Characterization of Molten Polymer-Drug Dispersions as a Predictive Tool for Pharmaceutical Hot-Melt Extrusion Processability.

Authors:  Jeroen Van Renterghem; Chris Vervaet; Thomas De Beer
Journal:  Pharm Res       Date:  2017-08-15       Impact factor: 4.200

9.  Spatial characterization of hot melt extruded dispersion systems using thermal atomic force microscopy methods: the effects of processing parameters on phase separation.

Authors:  Jonathan G Moffat; Sheng Qi; Duncan Q M Craig
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

10.  Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.

Authors:  T Quinten; G P Andrews; T De Beer; L Saerens; W Bouquet; D S Jones; P Hornsby; J P Remon; C Vervaet
Journal:  AAPS PharmSciTech       Date:  2012-09-11       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.